628 antibodies registered
| Antibody ID ∧ ∨ | Antibody name ∧ ∨ | Epitope ID ∧ ∨ | Epitope name ∧ ∨ | Recognition region ∧ ∨ |
|---|---|---|---|---|
| AN0321 | HK-249 | EP0086 | Heparan Sulfate | -[GlcA(b1-4)GlcNSO3(a1-4)]n- (GlcA-GlcNS) |
| AN0337 | HS3A8 | EP0086 | Heparan Sulfate | highly sulfated domains within Heparan sulfate |
| AN0455 | HS3B7 | EP0086 | Heparan Sulfate | -{IdoA(a1-4)[HSO3(-6)]GlcNSO3(a1-4)}- (IdoA-GlcNS6S) |
| AN0332 | HS4C3 | EP0086 | Heparan Sulfate | -{[HSO3(-6)]GlcNSO3(a1-4)[HSO3(-2)]IdoA(a1-4)}- (GlcNS6S-IdoA2S) -{[HSO3(-6)][HSO3(-3)]GlcNSO3(a1-4)[HSO3(-2)]IdoA(a1-4)}- (GlcNS6S3S-IdoA2S) 3-O-sulfated HS stractures |
| AN0336 | HS4E4 | EP0086 | Heparan Sulfate | -{GlcNSO3(a1-4)[HSO3(-2]IdoA(a1-4)}- (GlcNS-IdoA2S) |
| AN0452 | J403 / J-403 | EP0086 | Heparan Sulfate | -[GlcA(b1-4)GlcN(a1-4)]n- (GIcA-GlcN) |
| AN0456 | JM13 / JM-13 | EP0086 | Heparan Sulfate | -{[HSO3(-2)]GlcA(b1-4)GlcNSO3(a1-4)}n- (GlcA2S-GlcNS) -{[HSO3(-2)]GlcA(b1-4)GlcN(a1-4)}n- (GlcA2S-GlcN) |
| AN0331 | MW3G3 | EP0086 | Heparan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- (IdoA2S-GlcNAc) |
| AN0318 | NAH46 | EP0086 | Heparan Sulfate | -[GlcA(b1-4)GlcNAc(a1-4)]n- (GlcA-GlcNAc) |
| AN0457 | RB4EA12 | EP0086 | Heparan Sulfate | -{IdoA(a1-4)[HSO3(-6)]GlcNSO3(a1-4)}- (IdoA-GlcNS6S) |
| AN0451 | 3G10 | EP0087 | Delta-Heparan Sulfate | Heparan sulfate neo-epitope generated by digesting heparan sulfate with heparitinase from Flovobacterium heparinum |
| AN0331 | MW3G3 | EP0088 | Acharan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- (IdoA2S-GlcNAc) |
| AN0228 | NCC-ST-421 | EP0090 | Dimeric Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
| AN0229 | 43-9F | EP0091 | Lewis a- Lewis x Hybrid Antigen | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
| AN0228 | NCC-ST-421 | EP0091 | Lewis a- Lewis x Hybrid Antigen | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
| AN0230 | IMH2 | EP0092 | Trifucosyl-Lewis b Antigen | Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
| AN0264 | FH4 / FH-4 | EP0093 | Dimeric Lewis x | Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
| AN0257 | KH1 | EP0094 | Trifucosyl-Lewis y Antigen | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
| AN0268 | NUH2 / NUH-2 | EP0095 | Disialyl I | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(1-4)GlcNAc(b1-)-R |
| AN0563 | DMAb-21 | EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc-R Neu5Gc(a2-3)Gal(b1-3)[Neu5Gc(a2-6)]GlcNAc-R |
| AN0564 | DMAb-22 | EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc-R Neu5Gc(a2-3)Gal(b1-3)[Neu5Gc(a2-6)]GlcNAc-R |
| AN0277 | FH9 / FH-9 | EP0096 | Disialyl Lewis c | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
| AN0279 | RM2 | EP0097 | GalNAc Disialyl Lc4 (Hexasaccharide) | GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-3)Gal-R |
| AN0278 | 5F3 | EP0098 | Disialyl Gb5 | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
| AN0449 | RM1 | EP0099 | Monosialyl Gb5 | Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc(b1-1)Cer |